DYSPORT (Ispen Pty Ltd)
Product name
DYSPORT
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
194 working days (255)
Active ingredients
clostridium botulinum type A toxin - haemagglutinin complex
Registration type
EOI
Indication
DYSPORT is now also indicated for the symptomatic treatment of:
- focal spasticity affecting the upper limbs in adults.
- focal spasticity affecting the lower limb in adults.
- lower limb focal spasticity in children aged 2 years of age or older.